Case Study: Hookipa Pharmaceuticals achieves 7x faster translational research insights with Elucidata’s Polly

Hookipa Pharmaceuticals gets 7x faster translational research insights with Elucidata

Hookipa Pharmaceuticals, a Boston-based clinical-stage therapeutics company, faced a challenge in analyzing voluminous and unharmonized clinical assay data sourced from multiple vendors for their translational research. This made data management and analysis a laborious and resource-intensive process. They partnered with vendor Elucidata to address this.

Elucidata implemented an end-to-end solution using its platform, Polly, to harmonize metadata, integrate patient metadata with assay data, and build a custom dashboard for visualization. This allowed Hookipa's scientists to accelerate their time to analysis by 7x, reducing it from one week to one day, and save over 1000 hours on manual data curation, thereby enhancing the quality of their translational research.

Hookipa Pharmaceuticals